DRREDDY — Dr Reddys Laboratories Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual income statement for Dr Reddys Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	215,452	246,697	280,111	326,439	337,002
Cost of Revenue
Gross Profit	135,480	163,649	190,713	218,605	214,610
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	189,427	194,498	215,480	258,005	291,655
Operating Profit	26,025	52,199	64,631	68,434	45,347
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	30,614	60,485	72,010	76,795	53,927
Provision for Income Taxes
Net Income After Taxes	21,781	45,073	55,779	57,252	41,576
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	21,825	45,073	55,779	56,551	41,960
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	21,825	45,073	55,779	56,551	41,960
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	33.2	55.9	66.1	68	53.5
Dividends per Share